Utility of self-report antiretroviral adherence for predicting HIV viral load among persons who inject drugs in Hai Phong Vietnam: assessing differences by methamphetamine use

References

• Bangsberg, D. R. (2008). Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. The Journal of Infectious Diseases, 197(Supplement_3), S272–S278. https://doi.org/10.1086/533415
   PubMedGoogle Scholar
• Been, S. K., Yildiz, E., Nieuwkerk, P. T., Pogány, K., Van De Vijver, D. A., & Verbon, A. (2017). Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART. PLoS One, 12(11), e0186912.
   PubMed Web of Science ®Google Scholar
• Calmy, A., Ford, N., Hirschel, B., Reynolds, S. J., Lynen, L., Goemaere, E., de la Vega, F. G., Perrin, L., & Rodriguez, W. (2007). Hiv viral load monitoring in resource-limited regions: Optional or necessary? Clinical Infectious Diseases, 44(1), 128–134. https://doi.org/10.1086/510073
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C. (2018). NCT03526939: DRug Use and Infections in Hai Phong ViEtnam among persons who inject drugs (DRIVE).
   Google Scholar
• Des Jarlais, D. C., Feelemyer, J., Arasteh, K., Huong, D. T., Oanh, K. T. H., Khue, P. M., Giang, H. T., Thanh, N. T. T., Moles, J. P., Vinh, V. H., Vallo, R., Quillet, C., Rapoud, D., Michel, L., Laureillard, D, & Nagot, N. (2021). The methamphetamine epidemic among persons who inject heroin in Hai phong, Vietnam. Journal of Substance Abuse Treatment, 126, 108320. https://doi.org/10.1016/j.jsat.2021.108320
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Thi Huong, D., Thi Hai Oanh, K., Khue Pham, M., Thi Giang, H., Thi Tuyet Thanh, N., … Nagot, N. (2016). Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. International Journal of Drug Policy, https://doi.org/10.1016/j.drugpo.2016.02.021
   Web of Science ®Google Scholar
• Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002). Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: The panel on clinical practices for treatment of HIV. Annals of Internal Medicine, 137(5), 381–433. https://doi.org/10.7326/0003-4819-137-5_Part_2-200209031-00001
   PubMed Web of Science ®Google Scholar
• Ehrenkranz, P., Rosen, S., Boulle, A., Eaton, J. W., Ford, N., Fox, M. P., Grimsrud, A., Rice, B. D., Sikazwe, I., & Holmes, C. B. (2021). The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals. PLOS Medicine, 18(5), e1003651. https://doi.org/10.1371/journal.pmed.1003651
   PubMed Web of Science ®Google Scholar
• Feelemyer, J., Des Jarlais, D., Nagot, N., Duong Thi, H., Thi Hai, O. K., Pham Minh, K., Hoang Thi, G., Nham Thi Tuyet, T., Cleland, C. M., Arasteh, K., Caniglia, E., Chen, Y., Bart, G., Moles, J. P., Vu Hai, V., Vallo, R., Quillet, C., Rapoud, D., Sao, M. L., … Khan, M. R. (2023). Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai phong, Vietnam. International Journal of STD & AIDS, 9564624221142366. https://doi.org/10.1177/09564624221142366
   PubMed Web of Science ®Google Scholar
• Fulcher, J. A., Javanbakht, M., Shover, C. L., Ragsdale, A., Brookmeyer, R., Shoptaw, S., & Gorbach, P. M. (2021). Comparative impact of methamphetamine and other drug use on viral suppression among sexual minority men on antiretroviral therapy. Drug and Alcohol Dependence, 221, 108622. https://doi.org/10.1016/j.drugalcdep.2021.108622
   PubMed Web of Science ®Google Scholar
• Gebo, K. A., Fleishman, J. A., Conviser, R., Reilly, E. D., Korthuis, P. T., Moore, R. D., Hellinger, F. J., Mathews, W. C., & Crane, L. (2005). Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. JAIDS Journal of Acquired Immune Deficiency Syndromes, 38(1), 96–103. https://doi.org/10.1097/00126334-200501010-00017
   PubMed Web of Science ®Google Scholar
• Hall, H. I., Frazier, E. L., Rhodes, P., Holtgrave, D. R., Furlow-Parmley, C., Tang, T., Gray, K. M., Cohen, S. M., Mermin, J., & Skarbinski, J. (2013). Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Internal Medicine, 173(14), 1337–1344. https://doi.org/10.1001/jamainternmed.2013.6841
   PubMed Web of Science ®Google Scholar
• Hall, H. I., Gray, K. M., Tang, T., Li, J., Shouse, L., & Mermin, J. (2012). Retention in care of adults and adolescents living with HIV in 13 US areas. JAIDS Journal of Acquired Immune Deficiency Syndromes, 60(1), 77–82. https://doi.org/10.1097/QAI.0b013e318249fe90
   PubMed Web of Science ®Google Scholar
• King, C., Bart, G., Kunkel, L., & Korthuis, P. T. (2020). HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: Baseline results from the BRAVO study. BMC Public Health, 20(1), 1–8. https://doi.org/10.1186/s12889-019-7969-5
   PubMed Web of Science ®Google Scholar
• Lesko, C. R., Tong, W., Moore, R. D., & Lau, B. (2017). Retention, antiretroviral therapy use and viral suppression by history of injection drug use among HIV-infected patients in an urban HIV clinical cohort. AIDS and Behavior, 21(4), 1016–1024. https://doi.org/10.1007/s10461-016-1585-5
   PubMed Web of Science ®Google Scholar
• McCluskey, S. M., Boum 2nd, Y., Musinguzi, N., Haberer, J. E., Martin, J. N., Hunt, P. W., Marconi, V. C., Bangsberg, D. R., & Siedner, M. (2017). Appraising viral load thresholds and adherence support recommendations in the world health organization guidelines for detection and management of virologic failure. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76(2), 183. https://doi.org/10.1097/QAI.0000000000001479
   PubMed Web of Science ®Google Scholar
• Mee, P., Fielding, K. L., Charalambous, S., Churchyard, G. J., & Grant, A. D. (2008). Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. Aids (London, England), 22(15), 1971–1977. https://doi.org/10.1097/QAD.0b013e32830e4cd8
   PubMed Web of Science ®Google Scholar
• Mekuria, L. A., Prins, J. M., Yalew, A. W., Sprangers, M. A., & Nieuwkerk, P. T. (2016). Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring? Tropical Medicine & International Health, 21(7), 856–869. https://doi.org/10.1111/tmi.12709
   PubMed Web of Science ®Google Scholar
• Newman, H., & Hardie, D. (2021). HIV-1 viral load testing in resource-limited settings: Challenges and solutions for specimen integrity. Reviews in Medical Virology, 31(2), e2165. https://doi.org/10.1002/rmv.2165
   PubMed Web of Science ®Google Scholar
• Ngowi, K. M., Minja, L., Boer, I. M. S.-D., Aarnoutse, R. E., Masika, L., Sprangers, M. A., Pima, F. M., Mmbaga, B. T., Reiss, P., & Nieuwkerk, P. T. (2022). Predicting viral load suppression by self-reported adherence, pharmacy refill counts and real time medication monitoring among people living with HIV in Tanzania. AIDS Research and Therapy, 19(1), 51. https://doi.org/10.1186/s12981-022-00475-y
   PubMed Web of Science ®Google Scholar
• Nieuwkerk, P. T., de Boer-van der Kolk, I. M., Prins, J. M., Locadia, M., & Sprangers, M. A. (2010). Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding. SAGE Publications Sage UK.
   Google Scholar
• Nieuwkerk, P. T., & Oort, F. J. (2005). Self-Reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 38(4), 445–448. https://doi.org/10.1097/01.qai.0000147522.34369.12
   PubMed Web of Science ®Google Scholar
• Pepe, M. S. (2003). The statistical evaluation of medical tests for classification and prediction. Oxford University Press.
   Google Scholar
• Rebeiro, P., Althoff, K. N., Buchacz, K., Gill, M. J., Horberg, M., Krentz, H., Moore, R., Sterling, T. R., Brooks, J. T., Hogg, R., Klein, M., Martin, J., Mugavero, M., Rourke, S., Silverberg, M. J., Thorne, J., Gange, S. J., & Gebo, K. (2013). Retention among north American HIV–infected persons in clinical care, 2000–2008. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62(3), 356. https://doi.org/10.1097/QAI.0b013e31827f578a
   PubMed Web of Science ®Google Scholar
• Rutherford, G. W., Anglemyer, A., Easterbrook, P. J., Horvath, T., Vitoria, M., Penazzato, M., & Doherty, M. C. (2014). Predicting treatment failure in adults and children on antiretroviral therapy: A systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. Aids (London, England), 28, S161–S169. https://doi.org/10.1097/QAD.0000000000000236
   PubMed Web of Science ®Google Scholar
• Schooley, R. T. (2007). Viral load testing in resource-limited settings. Clinical Infectious Diseases, 44(1), 139–140. https://doi.org/10.1086/510090
   PubMed Web of Science ®Google Scholar
• Seed, P. (2010). DIAGT: Stata module to report summary statistics for diagnostic tests compared to true disease status.
   Google Scholar
• Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10(3), 227–245. https://doi.org/10.1007/s10461-006-9078-6
   PubMed Web of Science ®Google Scholar
• StataCorp, L. (2017). Stata Manual [SEM] example 42g—One and two-level mediation models (multilevel): two-level model with GSEM.
   Google Scholar
• Waruru, A., Muttai, H., Ng’ang’a, L., Ackers, M., Kim, A., Miruka, F., Erick, O., Okonji, J., Ayuaya, T., & Schwarcz, S. (2016). Positive predictive value of the WHO clinical and immunologic criteria to predict viral load failure among adults on first, or second-line antiretroviral therapy in Kenya. PLoS One, 11(7), e0158881. https://doi.org/10.1371/journal.pone.0158881
   PubMed Web of Science ®Google Scholar
• Williams, I., Churchill, D., Anderson, J., Boffito, M., Bower, M., Cairns, G., Cwynarski, K., Edwards, S., Fidler, S., Freedman, A., Geretti, A. M., Gilleece, Y., Horne, R., Johnson, M., Khoo, S., Leen, C., Marshall, N., Nelson, M., Orkin, C., … Youle, M. (2012). British HIV association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Medicine, 13(S2), 1–6. https://doi.org/10.1111/j.1468-1293.2012.01029.x
   Google Scholar
• World Health Organization. (2016). Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations–2016 update Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations–2016 update.
   Google Scholar
• Zhou, S., Toska, E., Langwenya, N., Edun, O., Cluver, L., & Knight, L. (2023). Exploring self-reported adherence measures to screen for elevated HIV viral load in adolescents: A South African cohort study. AIDS and Behavior, https://doi.org/10.1007/s10461-023-04068-2
   Web of Science ®Google Scholar